Trauma is the leading cause of death worldwide in individual's aged 18-39 with data from the WHO suggesting that worldwide almost 6 million deaths every year are directly attributable to trauma. Despite advances in trauma management, a significant proportion of these deaths are still due to haemorrhage. Death can occur early as a result of uncontrollable haemorrhage; in patients where surgical haemorrhage control is achieved subsequent morbidity and mortality can be attributed to effects of massive haemorrhage and large volume blood product transfusion.   This session will provide an update for the Feisty Study - An Australian multi-centre randomised, controlled trial studying the effects of rapid fibrinogen replacement in severely bleeding trauma patients.

  Learning outcomes:

• Improve awareness of the FEISTY study
• Describe the possible future implications 

If you attended this webinar, please complete the short feedback form to access your certificate.

Otherwise, click the box above once you have watched the presentation to mark it as complete. To be eligible for your certificate, you must watch over half the presentation and complete the feedback form to download your certificate.